As the Merck MMR whistle blower case proceeds toward a resolution that increasingly appears to spell doom for Merck’s scandal ridden MMRII blockbuster, HHS officials are scrambling to get Glaxo’s version of the MMR teed up to fill the coming vacuum.
childrenshealthdefense.org